Edition:
United States

Sinovac Biotech Ltd (SVA.OQ)

SVA.OQ on NASDAQ Stock Exchange Global Select Market

6.60USD
4:00pm EDT
Change (% chg)

$-0.16 (-2.37%)
Prev Close
$6.76
Open
$6.66
Day's High
$6.90
Day's Low
$6.50
Volume
9,996
Avg. Vol
12,106
52-wk High
$8.75
52-wk Low
$6.40

Chart for

About

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1)... (more)
No analyst recommendations are available for .

Overall

Beta: 0.36
Market Cap(Mil.): $406.94
Shares Outstanding(Mil.): 59.32
Dividend: --
Yield (%): --

Financials

  SVA.OQ Industry Sector
P/E (TTM): 14.61 28.53 31.56
EPS (TTM): 0.45 -- --
ROI: 23.54 13.22 12.88
ROE: 19.34 15.20 15.04

BRIEF-Sinovac Amends Shareholder Rights Plan

* SINOVAC BIOTECH LTD - ‍AMENDMENT EXTENDS EXPIRATION OF SHAREHOLDER RIGHTS PLAN FROM MARCH 27 TO MARCH 27, 2019​ Source text for Eikon: Further company coverage:

Mar 06 2018

Competitors

Earnings vs. Estimates